The FRED‐X Flow Diverter—An Australian Experience
The FRED X demonstrates favourable safety and efficacy profiles, with high technical success rates and satisfactory occlusion outcomes in an Australian setting. Thrombotic complications were rare, possibly reflecting the benefits of the antithrombotic coating, though larger studies with longer-term follow-up are needed for confirmation.
Authors
- Winston Chong (ORCID: https://orcid.org/0000-0001-7645-2861)
- Shuangyue Tan (ORCID: https://orcid.org/0000-0002-7713-9145)
- Anoop Madan
- Cameron Williams (ORCID: https://orcid.org/0000-0003-4952-8896)
- Conor Houlihan
- Carlos Chung
- Charles Li (ORCID: https://orcid.org/0000-0001-7088-6087)
Institutions
- The Alfred Hospital (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of Medical Imaging and Radiation Oncology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1111/1754-9485.13857
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Monash University